RBT‐1 preconditioning decreased SDC‐1 shedding into plasma by ~50% in each of two experimental injury models (endotoxemia, maleate‐induced AKI), consistent with the above clinical results. Here, SDC1 is linked to serum lipopolysaccharide activity.